Clean Yield Group’s Teva Pharmaceuticals TEVA Stock Holding History

Clean Yield Group’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-200	Closed	-$9K	–	265
2016 Q3	$9K	Hold	200	–	–	﹤0.01%	287
2016 Q2	$10K	Buy	+200	New	+$10.6K	﹤0.01%	257
2015 Q2	–	Sell	-650	Closed	-$40K	–	273
2015 Q1	$40K	Buy	+650	New	+$37.8K	0.02%	192

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Clean Yield Group's TEVA Position: Q4 2016 in Review

Clean Yield Group sold out of Teva Pharmaceuticals (TEVA) in Q4 2016, closing a stake of 200 shares — an estimated $9K sold.

Clean Yield Group first reported a position in TEVA in Q1 2015 and held it in 3 quarters. The position peaked at $40K in Q1 2015. 739 funds tracked by Wall St. Rank hold TEVA as of Q4 2016.

Clean Yield Group reported no remaining Teva Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
Clean Yield Group sold 200 Teva Pharmaceuticals shares in Q4 2016, an estimated $9K.
Clean Yield Group first reported a position in Teva Pharmaceuticals in Q1 2015 and held it in 3 quarters.
Clean Yield Group's Teva Pharmaceuticals position peaked at $40K in Q1 2015.
739 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2016.

Based on Clean Yield Group's 13F filing for Q4 2016, filed 24 Jan 2017.